Why Clarus Therapeutics Holdings Inc. (CRXT)’s Most Recent Report Reveals Some Hints About Its Future – News Heater
Home  »  Trending   »  Why Clarus Therapeutics Holdings Inc. (CRXT)’s M...

Why Clarus Therapeutics Holdings Inc. (CRXT)’s Most Recent Report Reveals Some Hints About Its Future

Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) went up by 18.95% from its latest closing price compared to the recent 1-year high of $31.24. The company’s stock price has collected 14.91% of gains in the last five trading sessions.

Is It Worth Investing in Clarus Therapeutics Holdings Inc. (NASDAQ :CRXT) Right Now?

Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Clarus Therapeutics Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


The average price from analysts is $2.63, which is $2.83 above the current price. Today, the average trading volume of CRXT was 13.95M shares.

CRXT’s Market Performance

CRXT stocks went up by 14.91% for the week, with a monthly jump of 7.76% and a quarterly performance of -64.20%, while its annual performance rate touched -95.81%. The volatility ratio for the week stands at 12.40% while the volatility levels for the past 30 days are set at 14.46% for Clarus Therapeutics Holdings Inc. The simple moving average for the period of the last 20 days is 1.55% for CRXT stocks with a simple moving average of -84.21% for the last 200 days.

CRXT Trading at -38.37% from the 50-Day Moving Average

After a stumble in the market that brought CRXT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.65% of loss for the given period.

Volatility was left at 14.46%, however, over the last 30 days, the volatility rate increased by 12.40%, as shares sank -0.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -65.38% lower at present.

During the last 5 trading sessions, CRXT rose by +14.91%, which changed the moving average for the period of 200-days by -94.49% in comparison to the 20-day moving average, which settled at $0.4159. In addition, Clarus Therapeutics Holdings Inc. saw -82.62% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for CRXT

Current profitability levels for the company are sitting at:

  • -284.67 for the present operating margin
  • +80.51 for the gross margin

The net margin for Clarus Therapeutics Holdings Inc. stands at -291.02.

The liquidity ratio also appears to be rather interesting for investors as it stands at 0.78.